Multi-omics approach to identify markers of resistance to endocrine therapy+CDK4/6 inhibitors in first line HR+/HER2-metastatic breast cancer (MBC) patients
CANCER RESEARCH(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined